Pre-Conference Workshops

Scientific Theory to Drug Development Workshop Sharing & Discussing Updates From Innovative Compounds in Early & Late Stage Development

10:30 am Inflammation at the Heart of Chronic Kidney Disease Patients: Anti-Interleukin Therapy?

  • Matt Devalaraja Chief Scientific Officer, Head of R&D, Corvidia Therapeutics

11:00 am Renal Lipids as a Potential Therapeutic Target for Kidney Disease

  • Nick LaBella Chief Scientific Officer, ZyVersa Therapeutics

11:30 am Role of Vascular Smooth Muscle Cell (SMC) TRPV4 Channel in IschemiaReperfusion-Induced Renal Insufficiency in Neonatal Pigs

  • Hitesh Soni Renal Fibrosis Gene Therapy Lead , Renascent Biosciences

12:00 pm Break & Networking

12:15 pm Research Update in Polycystic Kidney Disease

  • Ron Perrone Scientific Director, Clinical & Translational Research Center; Professor, Tufts University School of Medicine

12:45 pm CKD DM199 Research Update

1:15 pm Pre-conference Discussion Ends